These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 23089320

  • 1. Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
    Chen YT, Chen WT, Huang WT, Wu CC, Chai CY.
    Kaohsiung J Med Sci; 2012 Oct; 28(10):545-9. PubMed ID: 23089320
    [Abstract] [Full Text] [Related]

  • 2. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ, Lee JY, Kim SH, Seo YJ, Lee JH, Park JK, Kim MH, Cinn YW, Cho KH, Yoon TY.
    Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
    Weinrach DM, Wang KL, Wiley EL, Laskin WB.
    Arch Pathol Lab Med; 2004 Oct; 128(10):1136-41. PubMed ID: 15387709
    [Abstract] [Full Text] [Related]

  • 4. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ, Fekete E, From L.
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [Abstract] [Full Text] [Related]

  • 5. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
    Mori T, Misago N, Yamamoto O, Toda S, Narisawa Y.
    J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N, McNiff J, Hui P, Manfioletti G, Tallini G.
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IGFBP7, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
    Li J, Yu Y, Yang Y, Wang L, Cao J, Liang X, Xiao X, Tu Y, Chen H.
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):382-5. PubMed ID: 21492256
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
    West KL, Cardona DM, Su Z, Puri PK.
    Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
    [Abstract] [Full Text] [Related]

  • 10. Collagen triple helix repeat containing-1 in the differential diagnosis of dermatofibrosarcoma protuberans and dermatofibroma.
    Wang L, Xiang YN, Zhang YH, Tu YT, Chen HX.
    Br J Dermatol; 2011 Jan; 164(1):135-40. PubMed ID: 20849518
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-2 expression in dermatofibroma and dermatofibrosarcoma protuberans.
    Adler N, Tsabari C, Sulkes J, Ad-El D, Feinmesser M.
    J Cutan Pathol; 2008 Jun; 35(6):532-5. PubMed ID: 18201240
    [Abstract] [Full Text] [Related]

  • 13. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M, Ihn H, Yamane K, Tamaki K.
    Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles.
    Hsi ED, Nickoloff BJ.
    J Dermatol Sci; 1996 Jan; 11(1):1-9. PubMed ID: 8867761
    [Abstract] [Full Text] [Related]

  • 16. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H, Mentzel T, Palmedo G, Hantschke M, Rütten A, Paredes BE, Schärer L, Guillen CS, Requena L.
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [Abstract] [Full Text] [Related]

  • 17. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
    Labonte S, Hanna W, Bandarchi-Chamkhaleh B.
    J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
    Calikoglu E, Augsburger E, Chavaz P, Saurat JH, Kaya G.
    J Cutan Pathol; 2003 Mar; 30(3):185-9. PubMed ID: 12641778
    [Abstract] [Full Text] [Related]

  • 20. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
    Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G.
    Mod Pathol; 2010 Mar; 23(3):434-8. PubMed ID: 20062007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.